Tag Archive | "Biocon"

Partnering Agreements with Biocon

Tags: ,


The Partnering Agreements with Biocon report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story

M&A activity for Biocon

Tags: , ,


In contrast to its active partnering, Biocon is not an active acquirer. In 2010, Biocon announced the acquisition of Biocon Biopharmaceuticals from CIMAB. This strategic move by Biocon is to focus on novel biologics in the treatment of psoriasis. Read the full story

Biocon: The first Indian biotech company to achieve many milestones

Tags: , ,


Biocon is an emerging biopharmaceutical enterprise that focuses on reducing the therapy costs associated with chronic diseases such as diabetes, cancer and autoimmune diseases. Read the full story

Biocon: Partnering activity 2009-2014

Tags: ,


From an enzyme manufacturing company into a fully integrated biotechnology company, Biocon has emerged as a market leader with several different products and services. Read the full story

Biocon: Company profile

Tags:


Read the full story

Bristol-Myers Squibb grabs pharma partners deal to Biocon’s oral insulin amid diabetes growth

Tags: , , , ,


In a pharma partners agreement, Biocon & Bristol-Myers Squibb, both top biotech/pharma companies, have agreed to sign on a licensing deal for its experimental biopharmaceutical drug IN-105, which is an orally administered insulin. Read the full story

BMS pharma partners with Biocon for development of oral insulin

Tags: , , , , ,


Biocon, a top big biotech enterprise is now close to inking a pharma partners deal with US-based biopharmaceuticals giant Bristol-Myers Squibb, to partner for the development and commercialization of its oral insulin product IN-105, which is currently undergoing late-stage clinical trials.

Read the full story

Big pharma & biotech leaders Abbott & Biocon agree in pharma partners deal

Tags: , , , , ,


Abbott Laboratories, a top big pharma company  announced a pharma partners agreement with the Indian biotechnology company Biocon Ltd to develop nutrition products for India, as the U.S. drugmaker steps up its push to tap a potentially big market Read the full story

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new1gif
e79banner300x150gif
e78banner300x150animgif